PL EN
  1. www.sciencepharma.pl
  2. Aktualności
  3. EMA: Concept paper on the need for a guideline on process validation of medicinal products containing biotechnology-derived proteins as active substance

EMA: Concept paper on the need for a guideline on process validation of medicinal products containing biotechnology-derived proteins as active substance

06.06.2011
This concept paper addresses the need to develop guidance on process validation of biotechnology derived active substances.
Źródło wiadomośći: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2011/06/WC500107128.pdf

kapitał ludzki

fundusz społeczny

Narodowe Centrum Badań i Rozwoju

innowacyjna gospodarka

rozwój regionalny